title: [Torecan-induced neuroleptic malignant syndrome].
abstract: Neuroleptic malignant syndrome (NMS) is an uncommon, life-threatening complication of treatment with neuroleptic drugs. Its main features are hyperthermia, extrapyramidal signs, and autonomic instability with fluctuating consciousness. It is believed that NMS is related to dopamine receptor blockade in the brain. We describe a case in a 52-year-old diabetic woman who developed NMS after taking Torecan (thiethylperazine), a phenothiazine drug, for 3 months to relieve dizziness. It is important to recognize this syndrome early and to treat immediately.
authors.affiliation: Dept. of Medicine B, Central Hospital of the Emek, Afula.
authors.forename: S
authors.initials: S
authors.lastname: Bulvik
authors.forename: Z
authors.initials: Z
authors.lastname: Shimoni
authors.forename: C L
authors.initials: CL
authors.lastname: Kaplan
mesh_terms: D004244:Dizziness / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D013847:Thiethylperazine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D013847:Thiethylperazine